Procalcitonin levels to guide antibiotic therapy in adults with non-microbiologically proven apparent severe sepsis: A randomised controlled trial.
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Objective: Some patients with the phenotype of severe sepsis may have no overt source of infection or identified pathogen. We investigated whether a procalcitonin-based algorithm influenced antibiotic use in patients with non-microbiologically proven apparent severe sepsis. Design: This multicentre, randomised, controlled, single-blind trial was performed in two parallel groups. Setting: Eight intensive care units in France. Participants: Adults with the phenotype of severe sepsis and no overt source of infection, negative microbial cultures from multiple matrices and no antibiotic exposure shortly before intensive care unit admission. Intervention: The initiation and duration of antibiotic therapy was based on procalcitonin levels in the experimental arm and on the intensive care unit physicians’ clinical judgement without reference to procalcitonin values in the control arm. Main outcome measure: The primary outcome was the proportion of patients on antibiotics on day 5 postrandomisation. Results: Over a 3-year period, 62/1250 screened patients were eligible for the study, of whom 31 were randomised to each arm; 4 later withdrew their consent. At day 5, 18/27 (67%) survivors were on antibiotics in the experimental arm, versus 21/26 (81%) controls (p=0.24; relative risk=0.83, 95% CI: 0.60 to 1.14). Only 8/58 patients (13%) had baseline procalcitonin <0.25 µg/l; in these patients, physician complied poorly with the algorithm. Conclusions: In intensive care unit patients with the phenotype of severe sepsis or septic shock and without an overt source of infection or a known pathogen, the current study was unable to confirm that a procalcitonin-based algorithm may influence antibiotic exposure. However, the premature termination of the trial may not allow definitive conclusions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Antibiotics are subject to changes in PK/PD parameters in sepsis and septic shock where resultant concentrations may be too low risking clinical failure, or too high leading to toxicity (Table 3) (237-239).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [238]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618 · cited 1×
“2 Gram-positive bacteria are involved in 30–50% of cases and Gramnegative bacteria in 25–30%,(1) with some regional variations.(2) Nevertheless, recent clinical trials included 5–30% of participants with a phenotype of septic shock and negative microbiological cultures.”
BackgroundAPACHE—acute physiology and chronic health evaluation: a physiologically based classification system
KNAUS, W. A., ZIMMERMAN, J. E., WAGNER, D. P., DRAPER, E. A., & LAWRENCE, D. E. (1981) · Critical Care Medicine · doi:10.1097/00003246-198108000-00008 · Cited by 2,189
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Self-citationVasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa067373 · Cited by 1,924
Gram-Negative Bacteremia: I. Etiology and Ecology
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240029006 · Cited by 1,362
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Self-citation
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
Schuetz, P., Wirz, Y., Sager, R., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007498.pub3 · Cited by 649
Self-citationUpdate on Procalcitonin Measurements
Meisner, M. (2014) · Annals of Laboratory Medicine · doi:10.3343/alm.2014.34.4.263 · Cited by 395
“org 269 of such studies always depend on the training and experience of the team, the level of implementation of the method, regional features, and the patients selected [60-62].”
BackgroundAntibiotic stewardship in the intensive care unit
Luyt, C.-E., Bréchot, N., Trouillet, J.-L., & Chastre, J. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 388
“Thus, intensivists are rightly reluctant to rely exclusively on biological markers when severe infection is suspected [37,38,43-47].”
Background2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., Nobre, V., Ramirez, P., Rouze, A., Salluh, J., et al. (2023) · Intensive Care Medicine · doi:10.1007/s00134-022-06956-y · Cited by 292
“This individualized strategy has been assessed in several RCT showing that biomarker guidance can safely decrease the duration of therapy in comparison with fixed duration [9, 64, 65, 75, 76].”
Wirz, Y., Meier, M. A., Bouadma, L., Luyt, C. E., Wolff, M., Chastre, J., Tubach, F., Schroeder, S., Nobre, V., Annane, D., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2125-7 · Cited by 265
“Annane (2013) [7] France ICU, multicenter 62 Hospital stay Severe sepsis without overt source of infection and negative blood culture Initiation and duration; R against AB: < 0.”
Self-citationPrkno, A., Wacker, C., Brunkhorst, F. M., & Schlattmann, P. (2013) · Critical Care · doi:10.1186/cc13157 · Cited by 260
“For PCT measurements three different PCT tests were used: Brahms PCT Kryptor [26,27,29,30], Brahms PCT LIA [28,31] and Brahms PCT-Q [32].”
BackgroundMethodInfluentialEgi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Journal of Intensive Care · doi:10.1186/s40560-021-00555-7 · Cited by 224
Role of procalcitonin use in the management of sepsis
Gregoriano, C., Heilmann, E., Molitor, A., & Schuetz, P. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.11.63 · Cited by 159
“In this context, the use of the host-response and blood infection marker procalcitonin (PCT) has gained much attention and has already been approved for guidance of antimicrobial therapies in patients with respiratory infection and sepsis (10-16).”
BackgroundHamade, B., & Huang, D. T. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.003 · Cited by 160
Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review
Wagner, B. L., FILICE, G. A., Drekonja, D. M., Greer, N. L., MacDonald, R. H., Rutks, I. R., Butler, M. E., & Wilt, T. J. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/599172 · Cited by 190
Westwood, M., Ramaekers, B., Whiting, P., Tomini, F., Joore, M., Armstrong, N., Ryder, S., Stirk, L., Severens, J., & Kleijnen, J. (2015) · Health Technology Assessment · doi:10.3310/hta19960 · Cited by 138
Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults
Pepper, D. J., Sun, J., Rhee, C., Welsh, J. A., Powers, J. H., Danner, R. L., & Kadri, S. S. (2019) · CHEST Journal · doi:10.1016/j.chest.2018.12.029 · Cited by 157
“Investigators concluded that PCT-based algorithms could potentially save government health systems millions of euros annually,(48) based on a decision tree analysis of six RCTs.(19-23,30) However, these six RCTs all had high or unknown risk of bias and do not mention whether an antibiotic stewardship program was used…”
BackgroundMethodUsing Procalcitonin to Guide Antibiotic Therapy
Rhee, C. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw249 · Cited by 128
“Annane (2013) [49] 8 ICUs (France) 58 patients with culture-negative severe sepsis Initiation and Discontinuation: withhold or stop antibiotics (<0.”
BackgroundIankova, I., Thompson-Leduc, P., Kirson, N. Y., Rice, B., Hey, J., Krause, A., Schonfeld, S. A., DeBrase, C. R., Bozzette, S., & Schuetz, P. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002928 · Cited by 106
“For example, while the study by Annane et al (24) included patients presenting with a “phenotype of severe sepsis or septic shock”, the study by Deliberato et al (27) only included patients with microbiologically confirmed infections.”
BackgroundResultInfluentialNishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Journal of Intensive Care · doi:10.1186/s40560-017-0270-8 · Cited by 118
Andriolo, B. N., Andriolo, R. B., Salomão, R., & Atallah, Á. N. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010959.pub2 · Cited by 117
Huang, H., Peng, J., Weng, L., Wang, C.-Y., Jiang, W., & Du, B. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0338-6 · Cited by 104
Egi, M., Ogura, H., Yatabe, T., Atagi, K., Inoue, S., Iba, T., Kakihana, Y., Kawasaki, T., Kushimoto, S., Kuroda, Y., et al. (2021) · Acute Medicine & Surgery · doi:10.1002/ams2.659 · Cited by 96
Biomarker-guided antibiotic therapy—strengths and limitations
Nora, D. G., Salluh, J. I., Martín‐Loeches, I., & Póvoa, P. M. S. R. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.04.04 · Cited by 96
Lam, S. W., Bauer, S. R., Fowler, R., & Duggal, A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002953 · Cited by 97
“Of note, for trials that provided more granular information regarding compliance rates (3, 5, 13), compliance depended on the recommendation; compliance was lower when a low procalcitonin level suggested antibiotics should be withheld or stopped and higher when a high procalcitonin level suggested continuation or init…”
BackgroundNishida, O., Ogura, H., Egi, M., Fujishima, S., Hayashi, Y., Iba, T., Imaizumi, H., Inoue, S., Kakihana, Y., Kotani, J., et al. (2018) · Acute Medicine & Surgery · doi:10.1002/ams2.322 · Cited by 85
Voermans, A., Mewes, J. C., Broyles, M. R., & Steuten, L. (2019) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2019.0113 · Cited by 82
“Significant effects of PCT use on mortality have not been reported in the literature (Annane et al., 2013; Deliberato et al., 2013).”
BackgroundPapp, M., Kiss, N., Baka, M., Trásy, D., Zubek, L., Fehérvári, P., Harnos, A., Turan, C., Hegyi, P. J., & Molnár, Z. (2023) · Critical Care · doi:10.1186/s13054-023-04677-2 · Cited by 90
“PCT protocol was used to stop ABs [16, 30, 31, 34, 35, 37–40, 42, 43, 45, 50–53], to start ABs [41, 46, 49] or both [10, 32, 33, 36, 44, 47, 48].”
MethodInfluentialKip, M. M. A., Kusters, R., IJzerman, M. J., & Steuten, L. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1064934 · Cited by 75
“and Annane et al.(31) report that adherence in their studies was low.”
BackgroundAACC Guidance Document on the Clinical Use of Procalcitonin
Chambliss, A. B., Patel, K., Colón-Franco, J. M., Hayden, J. A., Katz, S. E., Minejima, E., & Woodworth, A. L. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfad007 · Cited by 64
“The other 7 studies each obtained PCT measurements on enrollment and then at variable time intervals ranging from daily to every 5 to 7 days until ICU or hospital discharge (10-14, 16, 23).”
BackgroundMethodInfluentialSchüetz, P., Bolliger, R., Merker, M., Christ‐Crain, M., Stolz, D., Tamm, M., Luyt, C. E., Wolff, M., Schröder, S., Junior, V. A. N., et al. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1496331 · Cited by 64
Crayton, E., Richardson, M. A., Fuller, C., Smith, C. M., Liu, S., Forbes, G., Anderson, N., Shallcross, L. J., Michie, S., Hayward, A. C., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01564-1 · Cited by 62
“24] [31]) [24], with limited clarity as to what makes one antimicrobial stewardship programme more effective than another.”
BackgroundA proposal for a comprehensive approach to infections across the surgical pathway
Sartelli, M., Pagani, L., Iannazzo, S., Moro, M. L., Viale, P., Pan, A., Ansaloni, L., Coccolini, F., D’Errico, M. M., Agreiter, I., et al. (2020) · World Journal of Emergency Surgery · doi:10.1186/s13017-020-00295-3 · Cited by 65
Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us
Zhang, Y. Z., & Singh, S. (2015) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v4.i1.13 · Cited by 65
Maseda, E., Suárez-de-la-Rica, A., Anillo, V., Tamayo, E., García-Bernedo, C. A., Ramasco, F., Villagrán, M. J., Maggi, G., Giménez, M.-J., Aguilar, L., et al. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.12.014 · Cited by 53
“Large trials had demonstrated that PCT-guided antibiotic treatments allow for reduction in duration of antibiotic therapy in severe sepsis patients in the ICU setting [11,12,17,18,23,24].”
BackgroundPeng, F., Chang, W., Xie, J.-F., Sun, Q., Qiu, H.-B., & Yang, Y. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.05.034 · Cited by 49
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T.-A., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Journal of Intensive Care · doi:10.1186/s40560-025-00776-0 · Cited by 52
Kip, M. M. A., van Oers, J. A. H., Shajiei, A., Beishuizen, A., Berghuis, A. M. S., Girbes, A. R. J., de Jong, E., de Lange, D. W., Nijsten, M. W., IJzerman, M. J., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2234-3 · Cited by 57
Jeon, K., Suh, J. K., Jang, E. J., Cho, S., Ryu, H. G., Na, S., Hong, S., Lee, H. J., Kim, J. Y., & Lee, S. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e110 · Cited by 57
“908 Pulmonary 5 (21) 10 (35) 2 (18) 8 (31) Intraabdominal 8 (33) 11 (38) 5 (46) 11 (42) Urinary 9 (38) 4 (14) 3 (27) 4 (15) Skin and soft tissue 1 (4) 0 0 0 Catheter-related 0 0 0 0 Others 1 (4) 3 (10) 1 (9) 2 (8) Unknown 0 1 (3) 0 1 (4) Bacterial pathogen identified 12 (52) 15 (52) 0.”
Kubo, K., Sakuraya, M., Sugimoto, H., Takahashi, N., Kano, K., Yoshimura, J., Egi, M., & Kondo, Y. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006366 · Cited by 50
Management of neonatal sepsis in term newborns
Pont‐Thibodeau, G. D., Joyal, J., & Lacroix, J. (2014) · F1000Prime Reports · doi:10.12703/p6-67 · Cited by 43
“A large multicenter RCT evaluating whether procalcitonin levels could be used to guide antibiotic therapy in adults with non-microbiologically proven sepsis was interrupted early because of failure to demonstrate benefit [33].”
BackgroundZhang, Z., Smischney, N. J., Zhang, H., Poucke, S. V., Tsirigotis, P. D., Rello, J., Honoré, P. M., Kuan, W. S., Ray, J. J., Zhou, J., et al. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.08.03 · Cited by 41
“The risks of bias in included studies were mostly low or unclear (42-48).”
BackgroundGuidelines for the Use of Procalcitonin for Rational Use of Antibiotics
Chaudhry, D., Sharma, A., Govil, D., Hadda, V., Jain, N., Tiwari, P., Samavedam, S., Dixit, S., Govindagoudar, M. B., Khilnani, G. C., et al. (2022) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24326 · Cited by 39
Arulkumaran, N., Khpal, M., Tam, K., Baheerathan, A., Corredor, C., & Singer, M. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004267 · Cited by 36
“Secondary Infections The frequency of secondary infections was reported in clinical algorithm RCTs (n = 368) (20, 27), three fixed-duration RCTs (n = 692) (15, 16, 21), and six procalcitonin-guided RCTs (n = 3,082) (14, 17, 23, 26, 30, 31) (Supplementary Fig.”
BackgroundMethodAntimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
Kyriazopoulou, E., & Giamarellos‐Bourboulis, E. J. (2022) · Antibiotics · doi:10.3390/antibiotics11030367 · Cited by 38
“[42] Sepsis Multicenter—France Initiation-cessation PCT: 27 SOC: 26 Patients (%) under treatment at day 5: 67 vs.”
Mertz, D., Brooks, A. A., Irfan, N., & Sung, M. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14220 · Cited by 36
Duncan, E., Charani, E., Clarkson, J., Francis, J., Gillies, K., Grimshaw, J., Kern, W. V., Lorencatto, F., Marwick, C., McEwen, J., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa001 · Cited by 36
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
Antimicrobial Stewardship Programs in Inpatient Settings: A Systematic Review
FILICE, G. A., Drekonja, D. M., Greer, N. L., Butler, M. E., Wagner, B. L., MacDonald, R., Carlyle, M., Rutks, I. R., & Wilt, T. J. (2013) · Europe PMC (PubMed Central) · Cited by 34
Gutiérrez-Pizarraya, A., León-García, M. D. C., Juan-Idígoras, R. D., & Garnacho‐Montero, J. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1932462 · Cited by 27
Ali, W. A., Bazan, N. S., Elberry, A. A., & Hussein, R. R. S. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-020-02494-y · Cited by 27
Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis
Zhang, T., Wang, Y., Yang, Q., & Dong, Y. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2622-3 · Cited by 26
Management of Intra-Abdominal Infections: The Role of Procalcitonin
Tian, B. W. C. A., Agnoletti, V., Ansaloni, L., Coccolini, F., Bravi, F., Sartelli, M., Vallicelli, C., & Catena, F. (2023) · Antibiotics · doi:10.3390/antibiotics12091406 · Cited by 25
“Large trials have demonstrated that, even in severely septic patients in the ICU, the use of PCT guidance leads to shortened antibiotic durations [10,11,67,74,75,82,83].”
BackgroundMethodKim, C.-J. (2022) · Infection and Chemotherapy · doi:10.3947/ic.2022.0172 · Cited by 20
“Two studies used PCT-based algorithms for both use and discontinuation of antibiotics [174, 175], and showed no differences in duration of antibiotics use (–1.”
Biomarkers for risk stratification and antibiotic stewardship in elderly patients
Falcone, M., Bauer, M. W., Ferrer, R., Gavazzi, G., del Castillo, J. M. G., Pilotto, A., & Schüetz, P. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02388-w · Cited by 20
Procalcitonin Guided Antibiotic Stewardship
Kiya, G. T., Asefa, E. T., Abebe, G., & Mekonnen, Z. (2024) · Biomarker Insights · doi:10.1177/11772719241298197 · Cited by 25
Elnajdy, D., & El‐Dahiyat, F. (2022) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2022.2037701 · Cited by 15
Arslan, G., Besci, T., Özdemir, G., Evren, G., Tüzen, H. I., Prencuva, P., Turan, B., & Benligül, E. M. (2023) · Children · doi:10.3390/children10111731 · Cited by 18
“Several indicators of inflammation have been identified, including acute phase proteins such as C-reactive protein (CRP), albumin, and amyloid A. Additionally, blood infection markers such as procalcitonin have been described [5,6].”
BackgroundHeilmann, E., Gregoriano, C., Annane, D., Reinhart, K., Bouadma, L., Wolff, M., Chastre, J. E., Luyt, C. E., Tubach, F., Branche, A. R., et al. (2021) · Age and Ageing · doi:10.1093/ageing/afab078 · Cited by 17
Self-citationLam, S. W., Bauer, S. R., & Duggal, A. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.10.017 · Cited by 14
Procalcitonin-guided antibiotic treatment in critically ill patients
Höhn, A., Heising, B., Schütte, J.-K., Schroeder, O., & Schröder, S. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1458-4 · Cited by 14
“However, both of the PCT studies in surgical ICU patients [30, 33] and two of the RCTs in a mixed ICU population [15, 31] did not exclusively Fig.”
BackgroundResultBiomarkers in sepsis: can they help improve patient outcome?
Kyriazopoulou, E., Poulakou, G., & Giamarellos‐Bourboulis, E. J. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000707 · Cited by 11
Macrae, D. J., Grieve, R., Allen, E., Sadique, Z., Betts, H., Morris, K., Pappachan, V. J., Parslow, R. C., Tasker, R. C., Baines, P. B., et al. (2014) · Cited by 11
Ammar, A. A., Lam, S. W., Duggal, A., Neuner, E. A., Bass, S. N., Guzmán, J. A., Wang, X., Han, X., & Bauer, S. R. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1887 · Cited by 10
Lau, M., Daniel, R., Hughes, K., Wootton, M., Hood, K., & Gillespie, D. (2022) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlac013 · Cited by 12
Antimicrobial Challenge in Acute Care Surgery
Schena, C. A., de’Angelis, G. L., Carra, M. C., Bianchi, G., & de’Angelis, N. (2022) · Antibiotics · doi:10.3390/antibiotics11101315 · Cited by 12
August, B., Kale-Pradhan, P. B., Giuliano, C. A., & Johnson, L. B. (2023) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2834 · Cited by 9
Omer, I., Abuthiyab, N., Zaid, N. A., Alkanani, R. S., Abualnaja, R., & Khan, G. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s377644 · Cited by 8
The expired breath carbon delta value is a marker for the onset of sepsis in a swine model
Bütz, D. E., Morello, S. L., Sand, J. M., Holland, G. N., & Cook, M. E. (2013) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c3ja50340b · Cited by 8
Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis
Stevenson, M., Forsyth, J. E., Hossain, A., Lall, R., Dark, P. M., collaborators, A.-S., Carlson, G., Naisbitt, M. J., Kay, D., Barber, S., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05732-w · Cited by 10
Antimicrobial Stewardship Programs: A Review of Recent Evaluation Methods and Metrics
Palmay, L., Walker, S. A. N., Leis, J. A., Taggart, L. R., Lee, C., & Daneman, N. (2014) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-013-0008-7 · Cited by 9
Utility of procalcitonin in a medical intensive care unit in Croatia
Brajković, A. V., Košuta, I., Tomek, D., Rora, M., Babel, J., Rogić, D., Vrančić, A. L., & Radonić, R. (2020) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01747-1 · Cited by 7
Procalcitonin for Antibiotic Treatment in Intensive Care Unit Patients
Layios, N., & Lambermont, B. C. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0360-2 · Cited by 6
“[42] failed to include patients because 80.”
Lehot, J.-J., Clec’h, C., Bonhomme, F., Brauner, M., Chemouni, F., de Mesmay, M., Gayat, É., Guidet, B., Hejblum, G., Hernu, R., et al. (2019) · Médecine Intensive Réanimation · doi:10.3166/rea-2018-0004 · Cited by 8
Self-citationProcalcitonin: Is This the Promised Biomarker for Critically Ill Patients?
Lacroix, J., & Fontela, P. S. (2016) · Journal of Pediatric Intensive Care · doi:10.1055/s-0036-1583279 · Cited by 6
Gregoriano, C., Wirz, Y., Heinsalo, A., Annane, D., Reinhart, K., Bouadma, L., Christ‐Crain, M., Kristoffersen, K. B., Damas, P., Junior, V. A. N., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13160-2 · Cited by 6
Self-citationSchneidewind, L. (2021) · Der Urologe · doi:10.1007/s00120-021-01506-8 · Cited by 3
“Interessanterweise verwendeten zwei der inkludierten Studien bereits den SOFA-Score und innerhalb des vorliegenden Cochrane Reviews wurden diesbezüglich Subgruppenanalysen durchgeführt, die aber keine statistisch signifikanten Ergebnisse erbrachten [30, 31].”
BackgroundAbdelrahman, E. A., Abdelazeem, E., Heikal, A. T., & Rezk, E. F. (2024) · The Egyptian Journal of Critical Care Medicine · doi:10.1007/s44349-024-00005-x · Cited by 1
Ding, L., Liu, M., & Sun, H. (2024) · Journal of Medical Biochemistry · doi:10.5937/jomb0-53853 · Cited by 1
“Another study published in Critical Care found that PCT levels were higher in non-survivors than in sepsis survivors (20).”
Raja, H. A. A., Afridi, M. K., Asad, F., Yasin, K., Uzair, M., Saleem, Y., Sardar, H., Bismil, I., Saeed, A., Ullah, I., et al. (2026) · Medical Principles and Practice · doi:10.1159/000551475 · Cited by 1
Matsushima, K., Khan, M., & Frankel, H. L. (2014) · Scandinavian Journal of Surgery · doi:10.1177/1457496913519772 · Cited by 1
“(17) were unable to confirm that a Pct-based algorithm may influence antibiotic exposure.”
BackgroundGestion de la durée de l’antibiothérapie selon les résultats des biomarqueurs
Quenot, J., Large, A., Dargent, A., Andreu, P., Bruyère, R., Barbar, S. D., & Charles, P. (2016) · Réanimation · doi:10.1007/s13546-016-1180-9 · Cited by 1
“[33] Réanimation Sepsis sévère sans infection retrouvée 58 30 (groupe guidé par la PCT)/28 (groupe témoin) = traitement des ATB non débuté si”
BackgroundLa procalcitonina in Terapia Intensiva: un grande futuro alle spalle?
Dorizzi, R. M., & Sette, P. (2016) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.1007/s13631-016-0112-z
Usage de la procalcitonine pour guider l’utilisation des antibiotiques en cas de sepsis
Tran, L., Ferland, C., & Ang, A. (2016) · Pharmactuel · Cited by 1
修, 西., 裕司, 小., 茂亮, 井., 敏明, 射., 均, 今., 江木盛時, 垣花泰之, 成樹, 久., 穣治, 小., 智仁, 貞., et al. (2016) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.24s0008
DIAGNOSTIC USEFULNESS OF PROCALCITONIN AND C-REACTIVE PROTEIN IN GRAM NEGATIVE BACTERIAL INFECTIONS.
Rajeswari, S., & Swaminathan, S. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/3814
Yoshitaka, H. A. R. A., & Nishida, O. (2017) · THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA · doi:10.2199/jjsca.37.811
Peragine, C. (2018) · TSpace (University of Toronto) · Cited by 1
Procalcitonin: Can it impact the length of antimicrobialsPreprint
Mannino, J. (2020) · doi:10.28971/532020mj68
(2017) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.1002/jja2.12182
Yang, Y., Huang, J., Yan, H., Li, X., Liu, P., Zhou, W., Zhang, X., Lu, X., & Xiao, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1101428
“High PCT concentrations are positively correlated with sepsis severity (Annane et al., 2013).”
BackgroundPapp, M., Kiss, N., Baka, M., Trásy, D., Zubek, L., Fehérvári, P., Harnos, A., Turan, C., Hegyi, P., & Molnár, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26626945
Chandran, R., Swetha, M., Dharshini, S., Sheeba, S., Sri, S. S., Nivaethika, M. H., & Sujitha, K. (2026) · Journal for Research in Applied Sciences and Biotechnology · doi:10.55544/jrasb.5.2.2
Nangia, V., & Dhar, R. (2026) · Cureus · doi:10.7759/cureus.113973
“However, length of hospital and ICU stay did not show a significant reduction, likely reflecting variability in institutional discharge policies or recovery outside the ICU [24].”
The Potential for Severe, Acute Inflammation to Impact Tissue Oxygenation—A Narrative Review
Nimmo, A. J., & Younsi, A. (2026) · Oxygen · doi:10.3390/oxygen6030022
“In terms of biomarkers, procalcitonin is an approved biomarker of infection for guiding the duration of antimicrobial therapy in sepsis [151,152].”
Mohammad Darvishi, M. N., Nouri, M., Rahimi, F., & Abadi, A. T. B. (2025) · Pegem Journal of Education and Instruction
Metadata
- Authors
- Annane, D., Maxime, V., Faller, J. P., Mezher, C., Clec'h, C., Martel, P., Gonzales, H., Feissel, M., Cohen, Y., Capellier, G., Gharbi, M., & Nardi, O.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Service de Réanimation polyvalente et maladies infectieuses, Centre Hospitalier General, Belfort, France
- L'Hôpital Nord Franche-Comté (FR)
- Service de Réanimation, Hôpital Avicenne, Bobigny Cedex, France
- Hôpital Ambroise-Paré (FR)
- Hôpital Rangueil (FR)
- Hôpital Avicenne (FR)
- Centre Hospitalier Universitaire de Besançon (FR)
- Corresponding author
- Annane, Djillali
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2013
- Volume
- 3
- Issue
- 2
- Pages
- e002186
- ISSN
- 2044-6055 (ISSN-L)
- PMC
- PMC3586059
- OpenAlex
- W2153575596
- Semantic Scholar
- 645edf46ce74991f49437319613eb496b8e8c610
- Cited by
- 94
- References
- 24
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 7 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 11 · 2016: 9 · 2015: 5 · 2014: 8 · 2013: 5
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMJ Open (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- procalcitonin, antibiotic stewardship, antibiotic duration, sepsis, septic shock, intensive care unit patients, antibiotic exposure, clinical judgment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
